Variations in serum transforming growth factor-β1 levels with gender, age and lifestyle factors of healthy Japanese adults

Disease Markers

Volumn 27, Issue 1, 2009, Pages 23-28

  Lin, Yingsong ^a   Nakachi, Kei ^b   Ito, Yoshinori ^c   Kikuchi, Shogo ^a   Tamakoshi, Akiko ^a   Yagyu, Kiyoko ^a   Watanabe, Yoshiyuki ^d   Inaba, Yutaka ^e  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e JISSEN WOMEN'S UNIVERSITY   (Japan)

Author keywords

Age; Gender; Obesity; Serum TGF 1; Smoking

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JAPAN; LIFESTYLE MODIFICATION; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

NICOTIANA TABACUM;

EID: 70350495647     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/529253     Document Type: Article

References (23)

1. R. Derynck, R.J. Akhurst and A. Balmain, TGF-beta signaling in tumor suppression and cancer progression, Nat Genet 29 (2001), 117-129.
2. M.O. Li, Y.Y. Wan, S. Sanjabi, A.K. Robertson and R.A. Flavell, Transforming growth factor-beta regulation of immune responses, Annu Rev Immunol 24 (2006), 99-146.
3. M.O. Li and R.A. Flavell, TGF-?: a master of all T cell trades, Cell 134 (2008), 392-404.
4. G.C. Blobe, W.P. Schiemann and H.F. Lodish, Role of transforming growth factor beta in human disease, N Engl J Med 342 (2000), 1350-1358.
5. V. Ivanovic, A. Melman, B. Davis-Joseph, M. Valcic and J. Geliebter, Elevated plasma levels of TGF-beta 1 in patients with invasive prostate cancer, Nat Med 1 (1995), 282-284.
6. S.M. Sheen-Chen, H.S. Chen, C.W. Sheen, H.L. Eng andW.J. Chen, Serum levels of transforming growth factor beta1 in patients with breast cancer, Arch Surg 136 (2001), 937-940.
7. K.S. Shim, K.H. Kim,W.S. Han and E.B. Park, Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection, Cancer 85 (1999), 554-561.
8. V. Ivanovíc, M. Demajo, K. Krtolica, M. Krajnovíc, M. Konstantinovic, V. Baltíc, G. Prtenjak, B. Stojiljkovíc, M. Breberina, Z. Neskovíc-Konstantinovíc, D. Nikolíc- Vukosavljevíc and B. Dimitrijevíc, Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients, Clin Chim Acta 371 (2006), 191-193.
9. H. Saito, S. Tsujitani, S. Oka, A. Kondo, M. Ikeguchi, M. Maeta and N. Kaibara, An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma, Anticancer Res 20 (2000), 4489-4493.
10. D.J. Grainger, D.E. Mosedale and J.C. Metcalfe, TGF-? in blood: a complex problem, Cytokine Growth Factor Rev 11 (2000) 133-145.
11. R. Dittadi, S. Meo, F. Fabris, G. Gasparini, D. Contri, M. Medici and M. Gion, Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments, Int J Biol Markers 16 (2001), 87-96.
12. A. Tamakoshi, T. Yoshimura, Y. Inaba, Y. Ito, Y.Watanabe, K. Fukuda, H. Iso and JACC Study Group, Profile of the JACC study, J Epidemiol 15 Suppl 1 (2005), S4-8.
13. Y. Ito, K. Nakachi, K. Imai, S. Hashimoto, Y. Watanabe, Y. Inaba, A. Tamakoshi, T. Yoshimura and JACC Study Group, Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor beta, soluble Fas, and superoxide dismutase activity for the JACC study. 1: J Epidemiol 15 Suppl 1 (2005), S67-73.
14. Y. Okamoto, Y. Gotoh, O. Uemura, S. Tanaka, T. Ando and M. Nishida, Age-dependent decrease in serum transforming growth factor (TGF)-beta 1 in healthy Japanese individuals; population study of serum TGF-beta 1 level in Japanese, Dis Markers 21 (2005), 71-74.
15. V. Nicolas, A. Prewett, P. Bettica, S. Mohan, R.D. Finkelman, D.J.Baylink and J.R. Farley, Age-related decreases in insulinlike growth factor-I and transforming growth factor-beta in femoral cortical bone from both men andwomen: implications for bone loss with aging, J Clin Endocrinol Metab 78 (1994), 1011-1016.
16. E. Porreca, C. Di Febbo, E. Vitacolonna, G. Baccante, A. Di Castelnuovo, A. Angelini, F. Febo, M. Di Nisio and F. Cuccurullo, Transforming growth factor-beta1 levels in hypertensive patients: association with body mass index and leptin, Am J Hypertens 9 (2002), 759-765.
17. M.C. Alessi, D. Bastelica, P. Morange, B. Berthet, I. Leduc, M. Verdier, O. Geel and I. Juhan-Vague, Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity, Diabetes 49 (2000), 1374-1380.
18. J.R. Long, P.Y. Liu, Y.J. Liu, Y. Lu, D.H. Xiong, L. Elze, R.R. Recker and H.W. Deng, APOE and TGF-beta1 genes are associated with obesity phenotypes, J Med Genet 40 (2003), 918-924.
19. R. Rosmond, M. Chagnon, C. Bouchard and P. Björntorp, Increased abdominal obesity, insulin and glucose levels in nondi- abetic subjects with a T29C polymorphism of the transforming growth factor-beta1 gene, Horm Res 59 (2003), 191-194.
20. M. Sopori, Effects of cigarette smoke on the immune system, Nat Rev Immunol 2 (2002), 372-1327
21. K. Nakachi and K. Imai, Environmental and physiological influences on human natural killer cell activity in relation to good health practices, Jpn J Cancer Res 83 (1992), 798-805.
22. K. Imai, S. Matsuyama, S. Miyake, K. Suga and K. Nakachi, Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population, Lancet 356 (2000), 1795-1799.
23. H. Takizawa, M. Tanaka, K. Takami, T. Ohtoshi, K. Ito, M. Satoh, Y. Okada, F. Yamasawa, K. Nakahara and A. Umeda, Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 163 (2001), 1476-1483.